Skip to main content

Table 1 Summary of patient characteristics and endpoints in control and intervention group

From: Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial

  Item Control group (n = 29) Intervention group (n = 31) p-Value
Patient characteristics Gender (female, %) 17 (58.6%) 19 (61.3%) 1.000
Living situation (home-cared, %) 22 (75%) 20 (64.5%) 0.4051
  Age (mean, SD, range; years) 79.5 ± 8.62 (66–99) 75.9 ± 6.87 (66–91) 0.0856
  Length of stay on ward (mean, SD, range; days) 10.1 ± 6.0 (3–29) 11.9 ± 8.5 (4–40) 0.0671
  Number of drugs during hospital stay (mean, SD, range) 16.3 ± 6.3 (7–32) 17.3 ± 7.3 (6–40) 0.5649
Drug-related readmissions (DRRs) Number 7 6  
Number of patients with DRR 7 3  
Adverse drug reactions (ADRs) during follow-up Number 14 21  
Number of preventable/ameliorable ADR (NCC-MERP category F-H) regarded as “preventable DRR” 4 1  
  Number of preventable/ameliorable ADR (NCC-MERP category D-E) 2 7  
Adverse drug reactions (ADRs) during hospital stay Number 9 9  
Potential inappropriate medication (PIM) One-year prevalence of PIM 20 31  
Changes in medication after discharge during follow-up Number per patient 16 ± 11 (3–47) 16 ± 10 (3–52)  
  1. SD Standard deviation